CD4 and neoplasm: We observed a significant reduction of CD45−GFP+ GSC005 tumor cells in mice given CD4+ T cells compared to the no transfer controls at day 10 post-tumor implantation, but a more significant reduction in tumor cell number in mice given M002-treated CD4+ T cells than mice transferred with saline-treated CD4+ T cells was noted (Fig. 3h).